• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 13, 2022 at 10:42: AM
via Sanofi SA (NASDAQ: SNY) said the next-gen COVID-19 vaccine candidate it has developed with GSK Plc (NASDAQ: GSK) in two trials showed a potential to protect against the virus's main variants of concern when used as a booster.

article source
 




Top Bottom
Back
Quote